DNLI NASDAQ
Denali Therapeutics Inc.
1W: -0.5%
1M: -4.7%
3M: -4.4%
YTD: +18.6%
1Y: +35.1%
3Y: -34.1%
5Y: -64.2%
$18.64
-0.66 (-3.42%)
Weekly Expected Move ±7.0%
$16
$17
$19
$20
$21
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-508M
Net Income
-11.9% YoY
$-419M
Free Cash Flow
-9.1% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-45.3%
ROA-40.3%
ROIC-229.7%
Valuation
P/E-6.8
P/B3.8
EV/EBITDA-5.3
Leverage
Debt/Equity0.04
Current Ratio9.16
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z13.18
Beneish M0.00